BFBing Feng

Bing Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bing Feng has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Bowen Zhang

    State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China

    1 shared publication
  • Chutian Li

    Department of Pathology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China

    1 shared publication
  • Dinghong Wu

    Research Group of Material Basis of Chinese Medicine, The Second Clinical Hospital Guangzhou University of Chinese Medicine Guangzhou China

    1 shared publication
  • Guangjuan Zheng

    State Key Laboratory of Dampness Syndrome of Chinese Medicine The Second Clinical College of Guangzhou University of Chinese Medicine Guangzhou China

    1 shared publication
  • Guanzhuo Li

    State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China

    1 shared publication
  • Hongying Liu

    Department of Pathology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Upregulated SKP2 Empowers Epidermal Proliferation Through Downregulation of P27 Kip1

    by Lipeng Tang, Bowen Zhang, Guanzhuo Li, Xinmin Qiu, Zixin Dai, Hongying Liu, Ying Zhu, Bing Feng, Zuqing Su, Wenhui Han, et al.

    Tang L, et al. Ann Dermatol. 2024 May;36:e41. https://doi.org/10.5021/ad.23.118


  • Intracardiac basic fibroblast growth factor and transforming growth factor-beta 1 mRNA and their proteins expression level in patients with pressure or volume-overload right or left ventricular hypertrophy

    by Zuo Yun He, Bing Feng, Sheng Li Yang, Hui Lan Luo

    The aim of the study was to investigate the pathogenic role of intracardiac basic fibroblast growth factor (bFGF) and transforming growth factor beta-1 (TGF beta-1) mRNA and their protein expression level in patients with ventricular volume or pressure-overload. Myocardial hypertrophy is responsiveness of cardiomyocytes and interstitial cells to ventricular stress produced by ventricular preload or/and afterload and a series of growth factors. However, the molecular mechanism by which the changes of bFGF and TGF beta-1 mRNA and their protein expression level in patients with volume or pressure-overload lead to distinct forms of cardiac hypertrophy is unclear. 32 patients were divided into two groups: 16 patients with cardiac volume overload leading to left ventricular hypertrophy (VG) and 16 patients with pressure overload leading to right ventricular hypertrophy (PG), respectively, as compared with 5 unexpected deaths of noncardiac disease (CG), which is determinated by echocardiography and/or pathologic examination following operation; intracardiac bFGF and TGF beta-1 mRNA and their protein expression level were determined by immunohistochemistry and in situ hybridization as well as image analysis; cardiomyocytes and fibril collagen of type I and III were examined by haemotoxylin and eosin (HE) staining or sirius-red staining. Cardiocyte transverse diameter and fibril collagen of extracellular matrix, intracardiac bFGF and TGF beta-1 mRNA and their protein expression level in patients with volume or pressure-overload were significantly increased in both VG and PG, as compared with CG. This is the first paper to suggest that intracardiac bFGF and TGF beta-1 play a pivotal role in patients with pressure or volume-overload leading to right or left ventricular hypertrophy, composed of cardiomyocyte hypertrophy and extracellular matrix proliferation.